Brief: Tiziana Life Sciences Announces Positive Six-Month Clinical Results In Multiple Sclerosis Patients Treated With Intranasal Foralumab
16/10/2023 12:11
Oct 16 (Reuters) - Tiziana Life Sciences Ltd TLSA.O :
* TIZIANA LIFE SCIENCES ANNOUNCES POSITIVE SIX-MONTH
CLINICAL
RESULTS IN MULTIPLE SCLEROSIS PATIENTS TREATED WITH INTRANASAL
FORALUMAB
Source text for Eikon: ID:nGNXgz9rY
Further company coverage: TLSA.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Tiziana Life Sciences
See all newsBrief: Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis
U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara
U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
U.S. STOCKS ON THE MOVE-Oracle, Vanda, Keysight
Tiziana Life Sciences rises as nasal MS drug shows promise in early study